Insider trading · Q3 2026 · CIK 1501796

Aura Biosciences, Inc. (AURA) insider trading.

In Q3 2026, insiders at Aura Biosciences, Inc. reported 7 non-derivative transactions on 11 Forms 3, 4 and 5: 0 open-market purchases and 0 sales.

Transactions
7
Purchases (P)
0
Sales (S)
0
Net shares, P minus S
0
Insiders
7
Last filed
2026-09-01

Insiders

InsiderRelationshipTransactionsBuysSales
Person JulieOfficer · Chief People Officer100
Hopkins Janet JillOfficer · Chief Medical Officer100
Elazzouzi AmyOfficer · SVP, Finance & PAO100
Abu-Absi SusanOfficer · Chief Operating Officer100
Kratz EricaOfficer · Chief Reg. & Quality Officer100
Bender JeremyDirector100
Kilroy ConorOfficer · See Remarks100

Transactions

7 non-derivative rows, newest transaction first. Shares and prices as filed.
DateInsiderCodeSharesPriceOwned afterFiling
2026-09-01Person JulieA (A)107,611$0107,611Form 4
2026-09-01Hopkins Janet JillA (A)58,850$0380,190Form 4
2026-09-01Elazzouzi AmyA (A)23,540$0143,600Form 4
2026-09-01Abu-Absi SusanA (A)134,513$0134,513Form 4
2026-09-01Kratz EricaA (A)100,885$0100,885Form 4
2026-07-07Bender JeremyA (A)30,000$030,000Form 4
2026-07-01Kilroy ConorA (A)14,858$0232,693Form 4

Transaction codes in this quarter

Get AURA insider transactions through the API

Request with your API key
curl "https://sec-api.dev/api/v1/insider-transactions?period=2026q3&cik=1501796&limit=100" \
  -H "Authorization: Bearer $SEC_API_KEY"

Insider trading API guide · AURA company page · Aura Biosciences, Inc. on SEC.gov

Questions

Are insiders buying or selling Aura Biosciences, Inc. (AURA)?

In Q3 2026, insiders at Aura Biosciences, Inc. reported 7 non-derivative transactions on 11 Forms 3, 4 and 5: 0 open-market purchases and 0 sales. Grants, tax withholding and option exercises are counted as transactions but are not purchases or sales.

Where do these Aura Biosciences, Inc. insider trades come from?

From the SEC Insider Transactions Data Sets for Q3 2026, which republish the Forms 3, 4 and 5 filed on EDGAR. Each row links to its filing on SEC.gov.

Source: SEC Insider Transactions Data Sets, Q3 2026, retrieved 2026-10-27. Footnotes, derivative holdings and amendments are in the linked filings. Not investment advice.

Plain-text version for agents and LLMs: /insider-trading/aura.md

Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.